Comment
Author: Admin | 2025-04-28
Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States Generic Victoza® is the first-ever generic GLP-1 and supports increased demand for this category of therapies in the U.S. market.This launch adds to Teva’s continued commitment to its complex generic medicine portfolio.Liraglutide injection is indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus and reduce the risk of cardiovascular events in adults with type 2 diabetes mellitus and established cardiovascular disease. PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of an authorized generic of Victoza®1 (liraglutide injection 1.8mg), in the United States.“By launching an authorized generic for Victoza® (liraglutide injection 1.8mg), we are providing patients with type 2 diabetes another option for this important treatment,” said Ernie Richardsen, SVP, Head of U.S. Commercial Generics at Teva. “In addition to strengthening Teva's diverse complex generics portfolio, we are providing the first generic GLP-1 product to the U.S. marketplace, demonstrating once again our ability to sustain a generics powerhouse.”Victoza® had annual sales of $1.656 billion as of April 2024.2What is liraglutide injection?Liraglutide is an injectable prescription medicine used:along with diet and exercise to lower blood sugar (glucose) in adults and children who are 10 years of age and older with type 2 diabetes mellitus.to reduce the risk of major cardiovascular events such as heart attack, stroke or death in adults with type 2 diabetes mellitus with known heart disease.Liraglutide injection 1.8mg is not for use in people with type 1 diabetes. It should not be used with other medicines that contain liraglutide. It is not known if liraglutide injection is safe and effective to lower blood sugar (glucose) in children under 10 years of age.IMPORTANT SAFETY INFORMATIONWhat is the most important information I should know about liraglutide injection?Liraglutide injection may cause serious side effects, including:Possible thyroid tumors, including cancer. Tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be
Add Comment